Avalyn Pharma Inc. – Filings and Transcripts

NASDAQ: AVLN
Share price (9/30/26): $28.49
Market cap (9/30/26): $1.263 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement with pricing info

Initial registration of new securities – amended

Registration of securities on exchange

Initial registration of new securities – amended

Ownership Filter

Meyer Robert J.

Meyer Robert J.

Novo Holdings a/S

Norwest Venture Partners XV, LP

News Filter

Change in Directors, Officers or Compensation

Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Material Definitive Agreement, Financial Statements or Exhibits

Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients With Progressive Pulmonary Fibrosis

Reports First Quarter 2026 Financial Results and Recent Business Highlights

Proxies

No filings in this category.

Other Filter

Notice of effectiveness